Life Sciences companies are experiencing a period of unprecedented change. Driven by shifts in age and demographics, disease, the entry of new technologies, increased government regulations, and the pace of health care inflation, life sciences companies will have to dramatically change in order to cope with the future industry environment. The Life Sciences and Health Care global industry practice at Deloitte member firms worldwide can help you address these and other challenges in today's complex life sciences environment. Visit the Health Care page for related information.

	The Financial Times Pharma & Biotech Conference Learn how to capitalize on new opportunities for growth through new models and approahces to R&D, sales & marketing, pricing and regulation.
	Life Sciences Innovation in Emerging Markets Learn about emerging markets innovation opportunities and challenges and how innovation can be promoted and protected in emerging markets
	The Right Spice: Pharma Market Entry in India Traditional strategic commitment must give way to strategic flexibility when developing an India pharmaceutical market entry strategy.

Submit a request for proposal (RFP)